Characteristics | N (%) |
---|---|
Gender | |
Female | 48 (46.2) |
Age | |
< 65 | 69 (66.3) |
≥ 65 | 35 (33.7) |
Dialysis type | |
HD | 56 (53.8) |
PD | 48 (46.2) |
ESKD etiology | |
Hypertensive nephropathy | 21 (20.2) |
Diabetic nephropathy | 19 (18.3) |
Polycystic kidney diseases | 3 (2.9) |
Glomerulonephritis | 2 (1.9) |
Obstructive nephropathy | 2 (1.9) |
Amyloidosis | 1 (0.9) |
Miscellaneous | 24 (23.1) |
Unknown etiology | 32 (30.8) |
Comorbidities | |
Hypertension | 66 (63.5) |
Diabetes | 24 (23.1) |
Cardiovascular disease | 16 (15.4) |
Dyslipidemia | 11 (10.6) |
Number of comorbidities | |
0 | 23 (22.1) |
1 | 39 (37.5) |
2 | 19 (18.3) |
3 or more | 23 (22.1) |
Number of drugs | |
1–5 | 22 (21.2) |
6–10 | 69 (66.3) |
11–15 | 13 (12.5) |
Laboratory findings, mean ± SD | |
Glucose (mg/dL) | 127.5 ± 110.9 |
Bicarbonate (mmol/L) | 21.7 ± 4.1 |
Hb (g/dL) | 11.2 ± 1.7 |
HbA1c (%) | 6.7 ± 1.9 |
Ferritin (ng/mL) | 580.3 ± 725.0 |
Transferrin (mg/dL) | 30.5 ± 15.6 |
Potassium (mmol/L) | 4.2 ± 0.7 |
Phosphorus (mg/dL) | 5.0 ± 1.4 |
Calcium (mg/dL) | 8.8 ± 0.7 |
Vitamin D (nmol/L) | 11.5 ± 7.0 |
Parathormone (pg/mL) | 481.7 ± 469.9 |
LDL-cholesterol (mg/dL) | 92.6 ± 37.2 |